SEER logo

SEER Seer, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$2.08
-0.02 (-0.95%)

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advan…

Market Cap: $114.36Mseer.bio

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

115
115
Aug 11Aug 11

Quote

Day Range
$2.08 – $2.13
52-Week Range
$1.55 – $2.41
Volume
$126.3K
Market Cap
$114.36M
50-Day Avg
$1.97
200-Day Avg
$1.90
Prev Close
$2.10
Open
$2.10

Valuation & Ratios

P/E Ratio
-1.43
EPS
$-1.28
P/B Ratio
0.41
P/S Ratio
6.52
Debt/Equity
0.09
Current Ratio
12.84
Dividend Yield
+0.0%
Gross Margin
+49.7%

Returns & Efficiency

Return on Equity
-28.4%
Return on Assets
-24.9%
FCF Yield
-44.0%
EV/EBITDA
-1.13

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$16.12M$-73.60M$-1.28
2024$13.95M$-86.60M$-1.39
2023$15.18M$-86.28M$-1.35
2022$14.69M$-92.97M$-1.42
2021$6.39M$-71.17M$-1.13

Social Signal Score

66
5d
66
2 mentions
30d
66
2 mentions
60d
66
2 mentions
90d
66
2 mentions
news: 2

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $-0.26 per share

4of 7 quarters beat consensus

Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 11$-0.31 vs $-0.27miss
  • Wed, May 13$-0.30 vs $-0.29miss
  • Thu, Feb 26$-0.29 vs $-0.32beat
  • Thu, Nov 6$-0.32 vs $-0.32beat
  • Wed, Aug 6$-0.33 vs $-0.39beat
  • Tue, May 13$-0.34 vs $-0.37beat

Estimates and results for SEER via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

SEERhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsmarketbeat.com·3d ago·Positive

    Seer Q2 Earnings Call Highlights Seer NASDAQ: SEER reported second-quarter revenue of $3.1 million, down from $4.1 million a year earlier but up from $2.8 million in the first quarter, as the proteomics company cited continued pressure on academic and government funding and longer sales cycles among some commercial customers.

    View source ↗
  • Newsseekingalpha.com·3d ago·Positive

    Seer, Inc. (SEER) Q2 2026 Earnings Call Transcript Seer, Inc. (SEER) Q2 2026 Earnings Call Transcript

    View source ↗